Huadong Medicine

The Global Weight Loss Drug Market Is Shifting From Injections to Oral Medications—And Chinese Companies Are Playing Catch-Up

China Finance China SoftwareAstraZeneca, Eli Lilly, Healthcare, Huadong Medicine, Innovent Biologics, Jiangsu Hengrui Pharmaceuticals, Novo Nordisk, Pharmaceutical Industry

February 22, 2026

FreshFromChina organizes publicly available and confirmed data. If you spot an error or have a better/great reference, please let us know:
📫 [email protected]

FreshFromChina is intended as an informational tool only. Content associated with FreshFromChina is not considered opinions or advice (financial or otherwise).

[a dumb idea]

Get the Freshest from China, right to your inbox

Weekly updates on 📈 trends,
💻 tech, & 🧧 finance coming out of the Middle Kingdom.

⛩ oh and it’s free! ⛩

Name *

Email *

Please do not fill in this field.

Scroll to Top